PRESS/PUBLICATIONS

qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes—An improved method for assessment of tumor stage and prognosis

Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR

Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer

Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.

Hammarström S. Biomarker mRNAs as prognostic tools for lymph node analysis in colorectal cancer.

The chemokine CXCL16 is a new biomarker for lymph node analysis of colon cancer outcome.

Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.

Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.

Ectopic expression of the chemokine CXCL17 in colon cancer cells.

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.

Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.

Colon cancer: Detection of tumour cells in lymph nodes of colon cancer patients using real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR).

Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR.

Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.

Utility of the housekeeping genes 18S rRNA, β-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes.

Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study.

Redefined nomenclature for members of the carcinoembryonic antigen family.

Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat.

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Funded by